Eli Lilly and Company
LLYNYSEHealthcare● Active
$1,131.42
+$6.15(+0.55%)
Market Cap$1.07T
P/E Ratio—
52W High$1166.29
52W Low$623.78
Eli Lilly and Company (LLY) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LLY · as of 2026-06-08
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B |
| Depreciation & Amort. | $2.00B | $1.77B | $1.53B | $1.52B | $1.55B |
| Stock-Based Comp. | $0.63B | $0.65B | $0.63B | $0.37B | $0.34B |
| Change in Working Capital | ($8.09B) | ($5.38B) | ($3.06B) | ($0.00B) | ($1.01B) |
| Net Cash from Operations | $16.81B | $8.82B | $4.24B | $7.59B | $7.37B |
| Investing Activities | |||||
| Capital Expenditure | ($7.84B) | ($8.40B) | ($7.39B) | ($2.99B) | ($1.98B) |
| Purchases of Investments | ($0.65B) | ($0.78B) | ($0.83B) | ($0.71B) | ($1.01B) |
| Sales of Investments | $0.96B | $0.52B | $0.70B | $0.46B | $0.85B |
| Net Cash from Investing | ($10.97B) | ($9.30B) | ($7.15B) | ($3.76B) | ($2.87B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($4.11B) | ($2.50B) | ($0.75B) | ($1.50B) | ($1.25B) |
| Dividends Paid | ($5.38B) | ($4.68B) | ($4.07B) | ($3.54B) | ($3.09B) |
| Debt Issued / Repaid | $8.05B | $8.90B | $8.65B | ($0.06B) | $0.50B |
| Net Cash from Financing | ($2.21B) | $1.23B | $3.50B | ($5.41B) | ($4.13B) |
| Free Cash Flow | |||||
| Free Cash Flow | $8.97B | $0.41B | ($3.15B) | $4.60B | $5.39B |
| FCF Margin %(computed) | 13.77% | 0.92% | -9.24% | 16.12% | 19.02% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Eli Lilly and Company data
About Eli Lilly and Company (LLY) Cash Flow Statement
Eli Lilly and Company generated operating cash flow of $16.81B and free cash flow of $8.97B for 2025 — a FCF margin of 13.77%. Capital expenditure was ($7.84B).
Frequently asked questions
LLY · 4 questionsEli Lilly and Company generated free cash flow of $8.97B for 2025, up 2065.6% year-over-year.
LLY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08